PFIZER MANUFACTURING BELGIUM

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "CVBA KPMG Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "L. Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Beumer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Monique Slootmaeckers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Imane Nassah",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2023-05-30",
    "act_kind_objet": "2870 Puurs-Sint-Amands"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2023-05-05",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0400.778.165",
        "name": "PFIZER MANUFACTURING BELGIUM",
        "role": "other",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Geen overdracht van patrimoine; enkel wijziging van de woonplaats van bestuurders.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Imane Nassah",
    "org_rep_person_name": null
  },
  "summary_narrative": "De raad van bestuur van Pfizer Manufacturing Belgium besliste unaniem op 5 mei 2023 de woonplaats van de bestuurders te wijzigen, met ingang vanaf die datum. De bestuurders Jan Beumer, Luc Van Steenwinkel en Monique Slootmaeckers kiezen hun woonplaats op de zetel van de vennootschap. Daarnaast verleenden de bestuurders bijzondere machten aan advocaten van DLA Piper UK LLP om de publicatie van deze besluiten in het Belgisch Staatsblad te verwezenlijken.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "KPMG Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "L. Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Beumer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Monique Slootmaeckers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-12-20",
    "filing_date": "2021-10-15",
    "act_kind_objet": "VERRICHTING GELIJKGESTELD MET EEN FUSIE DOOR OVERNEMING"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2021-11-30",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0400.778.165",
        "name": "Pfizer Manufacturing Belgium",
        "role": "acquiring",
        "address": "2870 Puurs-Sint-Amands, Rijksweg 12",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pfizer Financial Services BV",
        "role": "absorbed",
        "address": "2870 Puurs-Sint-Amands, Rijksweg 12",
        "is_foreign": false,
        "legal_form": "besloten vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "2:8",
      "2:14"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen van de Overgenomen Vennootschap wordt zonder uitzondering of voorbehoud overgenomen onder algemene titel door de Overnemende Vennootschap.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2021-11-30"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium",
    "legal_form": "naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Peter VAN MELKEBEKE",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van Pfizer Manufacturing Belgium, naamloze vennootschap met zetel te Puurs-Sint-Amands, heeft op 30 november 2021 besloten tot de overname van Pfizer Financial Services BV, ook gevestigd te Puurs-Sint-Amands, in het kader van een verrichting gelijkgesteld met een fusie door overneming. De overname treedt juridisch en boekhoudkundig in werking op 30 november 2021, om 24.00 uur. Het gehele vermogen van de overgenomen vennootschap gaat onder algemene titel over op de overnemende vennootschap.",
  "co_filed_documents": [
    "uitgifte van het proces-verbaal",
    "twee volmachten"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "proposal",
  "notary": {
    "name": "Charlotte Peeters",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-10-22",
    "filing_date": "2021-10-11",
    "act_kind_objet": "Neerlegging fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2021-10-11",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0429.712.968",
        "name": "Pfizer Financial Services",
        "role": "absorbed",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "besloten vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0400.778.165",
        "name": "Pfizer Manufacturing Belgium NV",
        "role": "acquiring",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "12:7"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen, inclusief rechten en verplichtingen, van Pfizer Financial Services wordt overgenomen door Pfizer Manufacturing Belgium zonder liquidatie. De overname is gebaseerd op de volledige eigendom van alle aandelen van Pfizer Financial Services door Pfizer Manufacturing Belgium.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2021-11-30"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Charlotte Peeters",
    "org_rep_person_name": null
  },
  "summary_narrative": "Het bestuursorgaan van Pfizer Financial Services BV en Pfizer Manufacturing Belgium NV heeft een fusievoorstel ingediend overeenkomstig artikel 12:50 van het Wetboek van Vennootschappen en Verenigingen, met als doel een vereenvoudigde fusie door overname. Pfizer Manufacturing Belgium NV zal het gehele vermogen van Pfizer Financial Services BV overnemen zonder liquidatie, aangezien Pfizer Manufacturing Belgium al alle aandelen van de overgenomen vennootschap bezit. De fusie is gepland op basis van boekhoudkundige retroactiviteit vanaf 30 november 2021.",
  "co_filed_documents": [
    "fusievoorstel overeenkomstig artikel 12:50 van het Wetboek van vennootschappen en verenigingen met het oog op de met fusie door overneming gelijkgestelde verrichting tussen de naamloze vennootschap Pfizer Manufacturing Belgium en de besloten vennootschap Pfizer Financial Services"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": null,
  "notary": {
    "name": "Frederik Verhaeghe",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-02-09",
    "filing_date": "2021-02-02",
    "act_kind_objet": "Intrekken fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2020-12-08",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "intent_announcement",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0400.778.165",
        "name": "PFIZER MANUFACTURING BELGIUM",
        "role": "other",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pfizer Financial Services BV",
        "role": "other",
        "address": null,
        "is_foreign": true,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "NL"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": true,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het fusievoorstel met Pfizer Financial Services BV, een Nederlandse naamloze vennootschap, wordt ingetrokken. Geen overdracht van patrimoine vindt plaats.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Frederik Verhaeghe",
    "org_rep_person_name": null
  },
  "summary_narrative": "De raad van bestuur van Pfizer Manufacturing Belgium besloot, met eenparigheid van stemmen, op 8 december 2020 het fusievoorstel met Pfizer Financial Services BV in te trekken, dat eerder op 16 oktober 2020 was neergelegd. De beslissing werd genomen in het kader van Project LER, waarbij de fusie niet uitgevoerd zal worden. De raad verleende bijzondere machten aan advocaten van DLA Piper UK LLP om de publicatie van het intrekken van het fusievoorstel in het Belgisch Staatsblad te regelen.",
  "co_filed_documents": [],
  "detected_real_type": "intent_announcement",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 64622074.0,
      "delta_eur": -300000000.0,
      "before_eur": 364622074.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Frederik Verhaeghe",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2020-11-05",
    "filing_date": "2020-10-16",
    "act_kind_objet": "Neerlegging fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2020-10-15",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0429.712.968",
        "name": "Pfizer Financial Services",
        "role": "absorbed",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0400.778.165",
        "name": "Pfizer Manufacturing Belgium",
        "role": "acquiring",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen, inclusief rechten en verplichtingen, van Pfizer Financial Services wordt overgenomen door Pfizer Manufacturing Belgium. De overname is gebaseerd op de volledige concentratie van aandelen van Pfizer Financial Services in handen van Pfizer Manufacturing Belgium.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2020-11-30"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Frederik Verhaeghe",
    "org_rep_person_name": null
  },
  "summary_narrative": "Het bestuursorgaan van Pfizer Financial Services NV en Pfizer Manufacturing Belgium NV heeft een fusievoorstel ingediend overeenkomstig artikel 12:50 van het Wetboek van Vennootschappen en Verenigingen, met als doel een vereenvoudigde fusie door overneming. Pfizer Manufacturing Belgium zal Pfizer Financial Services overnemen zonder liquidatie, aangezien Pfizer Manufacturing Belgium al alle aandelen van Pfizer Financial Services bezit. De fusie wordt boekhoudkundig geacht te zijn uitgevoerd vanaf 30 november 2020.",
  "co_filed_documents": [
    "fusievoorstel overeenkomstig artikel 12:50 van het Wetboek van vennootschappen en verenigingen met het oog op de met fusie door overneming gelijkgestelde verrichting tussen de naamloze vennootschap Pfizer Manufacturing Belgium en de naamloze vennootschap Pfizer Financial Services"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 314642069.55,
      "delta_eur": 29595340.620000005,
      "before_eur": 285046728.93,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Olivier Declercq",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Steven Veyt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "KPMG Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "L. Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Beumer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Monique Slootmaeckers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Patrick Simons",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Oliver Declercg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "Dirk Verbestel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "volmachtdrager / vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Sofie Depuydt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Deneve",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Gedelegeerd Bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "Voorzitter van de Raad van Bestuur",
      "person": {
        "rrn": null,
        "name": "P. Ginestet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "P. Duffy",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Voorzitter van de Raad van Bestuur",
      "person": {
        "rrn": null,
        "name": "P. Duffy",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "\u00D6. Baysal",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "G.G. Brouwers",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "E. Catthoor",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "P. De Backer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "C. De Waen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "D. Rapic",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Karl Aymanns",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "W. Van Effeltaire",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "afgevaardigd bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Deneve",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PHARMACIA"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}